D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 57 Citations 10,263 214 World Ranking 2448 National Ranking 83

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Cancer

Janaki Amin mainly investigates Internal medicine, Immunology, Hepatitis C virus, Virology and Viral load. He interconnects Gastroenterology, Surgery and Zidovudine in the investigation of issues within Internal medicine. His work deals with themes such as Mortality rate, Standardized mortality ratio, Confidence interval, Cause of death and Survival analysis, which intersect with Immunology.

Janaki Amin has included themes like Hepatocellular carcinoma, Cirrhosis and Hepatitis C in his Hepatitis C virus study. His study in Hepatitis C is interdisciplinary in nature, drawing from both Liver disease and Hepatitis B. His work investigates the relationship between Virology and topics such as Cohort that intersect with problems in Pre-exposure prophylaxis, Men who have sex with men, Drug and Prospective cohort study.

His most cited work include:

  • Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. (269 citations)
  • Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study. (269 citations)
  • Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. (264 citations)

What are the main themes of his work throughout his whole career to date?

Janaki Amin mainly investigates Internal medicine, Immunology, Hepatitis C, Virology and Hepatitis C virus. His research in Internal medicine intersects with topics in Gastroenterology and Viral load. His study focuses on the intersection of Viral load and fields such as Regimen with connections in the field of Lopinavir and Confidence interval.

The Hepatitis C study combines topics in areas such as Epidemiology, Ribavirin, Sofosbuvir, Liver disease and Hepacivirus. His study in the fields of Virus and Coinfection under the domain of Virology overlaps with other disciplines such as Antibody-dependent cell-mediated cytotoxicity. His study looks at the relationship between Hepatitis C virus and topics such as Clinical trial, which overlap with Cirrhosis.

He most often published in these fields:

  • Internal medicine (57.03%)
  • Immunology (26.51%)
  • Hepatitis C (32.13%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (57.03%)
  • Hepatitis C (32.13%)
  • Hepatitis C virus (26.91%)

In recent papers he was focusing on the following fields of study:

Janaki Amin spends much of his time researching Internal medicine, Hepatitis C, Hepatitis C virus, Virology and Incidence. His studies in Internal medicine integrate themes in fields like Drug and Sofosbuvir. His Hepatitis C research is multidisciplinary, incorporating elements of Pegylated interferon, Ribavirin and Liver disease.

His research integrates issues of Cirrhosis and Confidence interval in his study of Hepatitis C virus. His work in the fields of Virology, such as Viral load, intersects with other areas such as Practitioner research. As part of one scientific family, he deals mainly with the area of Incidence, narrowing it down to issues related to the Cohort, and often Emtricitabine, Pre-exposure prophylaxis, Rate ratio and Prospective cohort study.

Between 2016 and 2021, his most popular works were:

  • Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression (236 citations)
  • Life expectancy of HIV‐positive people after starting combination antiretroviral therapy: a meta‐analysis (152 citations)
  • Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. (132 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

His main research concerns Hepatitis C, Hepatitis C virus, Internal medicine, Virology and Cohort study. Janaki Amin works mostly in the field of Hepatitis C, limiting it down to topics relating to Liver disease and, in certain cases, Hepatitis, Risk factor and Public health. Hepatitis C virus is a subfield of Immunology that Janaki Amin investigates.

His Internal medicine research is mostly focused on the topic Clinical trial. When carried out as part of a general Virology research project, his work on Viral load is frequently linked to work in Government department and Antibody-dependent cell-mediated cytotoxicity, therefore connecting diverse disciplines of study. Janaki Amin has researched Viral load in several fields, including Gold standard, Venipuncture, Point-of-care testing and Hepacivirus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression

Reem Waziry;Behzad Hajarizadeh;Jason Grebely;Janaki Amin.
Journal of Hepatology (2017)

448 Citations

The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

Jason Grebely;Kimberly A Page;Rachel Sacks-Davis;Martin Schim van der Loeff.
Hepatology (2014)

414 Citations

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.

Andrew Carr;Cassy Workman;Don E. Smith;Jennifer Hoy.
JAMA (2002)

394 Citations

Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population.

Alison J. Rodger;Rebecca Lodwick;Mauro Schechter;Steven Deeks.
AIDS (2013)

381 Citations

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.

Allison Martin;Don E Smith;Andrew Carr;Clare Ringland.
AIDS (2004)

378 Citations

Life expectancy of HIV‐positive people after starting combination antiretroviral therapy: a meta‐analysis

S Teeraananchai;SJ Kerr;SJ Kerr;J Amin;K Ruxrungtham.
Hiv Medicine (2017)

332 Citations

Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study

Janaki Amin;Matthew G Law;Mark Bartlett;John M Kaldor.
The Lancet (2006)

324 Citations

Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial

Allison Martin;Mark Bloch;Janaki Amin;David Baker.
Clinical Infectious Diseases (2009)

286 Citations

Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.

Andrew E. Grulich;Rebecca Guy;Janaki Amin;Fengyi Jin.
The Lancet HIV (2018)

236 Citations

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.

Jason Grebely;Olav Dalgard;Brian Conway;Evan B Cunningham.
The Lancet Gastroenterology & Hepatology (2018)

235 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Janaki Amin

Gregory J. Dore

Gregory J. Dore

University of New South Wales

Publications: 146

Jason Grebely

Jason Grebely

University of New South Wales

Publications: 115

Margaret Hellard

Margaret Hellard

Burnet Institute

Publications: 107

Andrew R. Lloyd

Andrew R. Lloyd

University of New South Wales

Publications: 76

David A. Cooper

David A. Cooper

University of New South Wales

Publications: 74

Lisa Maher

Lisa Maher

University of New South Wales

Publications: 63

Gail V. Matthews

Gail V. Matthews

University of New South Wales

Publications: 58

Anthony D. Kelleher

Anthony D. Kelleher

University of New South Wales

Publications: 55

Stephen J. Kent

Stephen J. Kent

University of Melbourne

Publications: 54

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 53

Matthew Law

Matthew Law

University of New South Wales

Publications: 47

Maria Prins

Maria Prins

University of Amsterdam

Publications: 43

Jennifer F Hoy

Jennifer F Hoy

Monash University

Publications: 42

Andrew Carr

Andrew Carr

University of Oxford

Publications: 39

Peter Reiss

Peter Reiss

University of Amsterdam

Publications: 36

Andrew E. Grulich

Andrew E. Grulich

University of New South Wales

Publications: 36

Trending Scientists

Lori A. Clarke

Lori A. Clarke

University of Massachusetts Amherst

Alexander Ivanovich Aptekarev

Alexander Ivanovich Aptekarev

Keldysh Institute of Applied Mathematics

Michael A. Rothman

Michael A. Rothman

Intel (United States)

Michel Dupuis

Michel Dupuis

University at Buffalo, State University of New York

Jacek Lipkowski

Jacek Lipkowski

University of Guelph

Haiyuan Yu

Haiyuan Yu

Cornell University

Caroline E. R. Lehmann

Caroline E. R. Lehmann

University of Edinburgh

Iain M. Hagan

Iain M. Hagan

University of Manchester

Eric A. Barnard

Eric A. Barnard

University of Cambridge

Eric C. Grimm

Eric C. Grimm

University of Minnesota

Gary E. Thomas

Gary E. Thomas

University of Colorado Boulder

Mike Angstadt

Mike Angstadt

University of Michigan–Ann Arbor

Daniel Bullock

Daniel Bullock

Boston University

Howard M. Grey

Howard M. Grey

La Jolla Institute For Allergy & Immunology

Kenneth B. Wells

Kenneth B. Wells

University of California, Los Angeles

Simon N. Rogers

Simon N. Rogers

Edge Hill University

Something went wrong. Please try again later.